Key takeaways
- The UCLA Research Park will occupy former mall site, a 700,000-square-foot property 2 miles from the Westwood campus.
- The research park will house the California Institute for Immunology and Immunotherapy at UCLA and the UCLA Center for Quantum Science and Engineering, as well as programs across the disciplines.
- This acquisition was made possible in part by an intended $500 million investment from the state of California, with $200 million already allocated.
- The California Institute for Immunology and Immunotherapy is also supported by a group of founding donors led by Meyer Luskin, Dr. Gary Michelson, Dr. Eric Esrailian, Dr. Arie Belldegrun, Sean Parker and Michael Milken.
UCLA has acquired the former Westside Pavilion shopping mall, which the university will transform into the UCLA Research Park — bringing together scholars and industry experts from around the world to create a nexus for discovery and innovation that will benefit Southern California and beyond.
“This acquisition will be absolutely transformative for UCLA, our great city and the world. Gov. Gavin Newsom and the California Legislature helped make this possible through a generous state investment, and we are deeply thankful for their support,” said UCLA Chancellor Gene Block. “We will remake the empty former mall into a state-of-the-art hub of research and innovation that will bring scholars from different higher education institutions, corporate partners, government agencies and startups together to explore new areas of inquiry and achieve breakthroughs that will serve our global society.”
The 700,000-square-foot property, located 2 miles south of the Westwood campus, will initially host two multidisciplinary research centers: the California Institute for Immunology and Immunotherapy at UCLA and the UCLA Center for Quantum Science and Engineering.
The new UCLA Research Park is made possible in part by an intended $500 million investment, with $200 million already allocated, from the state of California to establish and fund the immunology and immunotherapy institute at UCLA. The institute is also supported by a group of founding donors from the biotechnology, academic, entrepreneurship and philanthropic communities led by Meyer Luskin, Dr. Gary Michelson, Dr. Eric Esrailian, Dr. Arie Belldegrun, Sean Parker and Michael Milken.
